Latest antibody News

Recipients Of CIMED Project Grants 2027-2029 At MedH
What To Know About Tick-Borne Alpha-Gal Syndrome
WHO issues first ever guidance to advance child-focused dengue treatments
Enhertu recommended for approval in the EU by CHMP for patients with previously treated HER2-positive metastatic solid tumours
Statement on the antigen composition of COVID-19 vaccines
Enhertu approved in the US for two new indications for patients with HER2-positive early breast cancer
Nobel mini-symposium at KI on advances in antibody diversification and engineering
Nobel Mini-Symposium on Advances in Antibody Diversification and Engineering at Karolinska Institutet
No Refrigeration Needed For Killer Disease Vaccine
Chronic bowel disease involves multiple types of inflammation happening at once
A half antibody that can fight on its own: a discovery that challenges conventional wisdom
WA delivers world-first protection for spring and summer-born babies
Types of data requested to inform May 2026 COVID-19 vaccine antigen composition deliberations
Enhertu granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
Precision tumor imaging with a fluorescence probe and engineered enzymes
Allergic to the cold? It’s a real thing and it can even kill
World-first Mouse That Makes Gene Activity Visible
Monash study shows subcutaneous delivery with hyaluronidase may boost effectiveness of cancer immunotherapy
Statement on the antigen composition of COVID-19 vaccines
Discovery about brain receptors may open the door to new Alzheimer’s treatments
UniSA Partners With Leading Global Biotech Company On New Therapies
Types of data requested to inform December 2025 COVID-19 vaccine antigen composition deliberations
New Antibody May Slow Kidney Damage
Precise Imaging Technique Confirms Hemoglobin Preservation in Dinosaur Bone
Botox: unlicensed injections are increasingly being linked to serious illness in the UK
Alzheimer’s: bacteria that causes stomach ulcers may protect the brain, our new research indicates
Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPa-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors
Statement on the antigen composition of COVID-19 vaccines
Why are some cats more allergenic than others? It’s not their coat length
Idarucizumab, levetiracetam, ustekinumab: how do drugs get their names and why are they so hard to pronounce?
Types of data requested to inform May 2025 COVID-19 vaccine antigen composition deliberations
Free RSV Immunisation For Newborns From Next Monday
NSW new free RSV immunisation for newborns from next Monday
Possible biomarker identified for Crohn’s disease with arthritis type
New Findings Could Improve Stroke Care
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
Stoking “good” antibodies key to reducing serious bee venom allergic reactions
Immunotherapy Against Cancer: How Therapeutic Antibodies do Their Job
Statement on the antigen composition of COVID-19 vaccines
Pioneering technique reveals images of disease in glorious technicolour
New infant RSV immunisation program to commence in 2025 to protect Tasmania’s most vulnerable
Why copper could be the key to treating a rare childhood cancer
Anticancer drugs could make immunotherapies more effective
Researchers discover new treatment for rare immune disease
Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites
NSW To Rollout New Free RSV Prevention Program In 2025
Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences
ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development